Clinical Trial Update: Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating gemcitabine plus oxaliplatin in metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN